Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

SCAI 2021: COVID-19 especially harmful for high-risk heart attack patients

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact." 

Thumbnail

SCAI unveils new cath lab guidelines at annual meeting

The new guidelines were endorsed by the American College of Cardiology, American Heart Association, Heart Rhythm Society and Clinical Policy Approval Committee.

Thumbnail

Guided antiplatelet therapy improves outcomes for PCI patients

The meta-analysis included data from 14 different studies investigating the differences between guided and standard antiplatelet therapy after PCI.

Thumbnail

Transseptal MViV for high-risk patients associated with 100% success rate after 1 year

Researchers explored data from one arm of the MITRAL early feasible study, sharing their findings in JACC: Cardiovascular Interventions. 

amputation amputee diabetes

Bill would bolster coverage of interventional radiology services to help Americans avoid amputations

Lawmakers recently introduced the Amputation Reduction and Compassion Act in the House, with bipartisan backing and support from the Society of Interventional Radiology

Thumbnail

FDA announces recall of Medtronic blood pump after reports of multiple injuries

The recall comes after multiple reports of electrical failure, which can cause the pump to smoke, give off a strong burning odor or stop working altogether. 

Thumbnail

TEER still beneficial for heart failure patients with an elevated mitral valve gradient

Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions.

M&A mergers and acquisitions business deal

Endologix acquires medical device company focused on peripheral artery disease

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.